UBS Group’s Aoxing Pharmaceutical Company Inc. AXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-22,423
| Closed | -$4K | – | 7236 |
|
|
2017
Q3 | $4K | Sell |
22,423
-522
| -2% | -$93 | ﹤0.01% | 6440 |
|
|
2017
Q2 | $7K | Buy |
+22,945
| New | +$7K | ﹤0.01% | 6065 |
|
|
2017
Q1 | – | Sell |
-25,556
| Closed | -$8K | – | 7055 |
|
|
2016
Q4 | $8K | Buy |
25,556
+21,081
| +471% | +$6.6K | ﹤0.01% | 6094 |
|
|
2016
Q3 | $3K | Sell |
4,475
-5,595
| -56% | -$3.75K | ﹤0.01% | 6413 |
|
|
2016
Q2 | $7K | Buy |
10,070
+8,573
| +573% | +$5.96K | ﹤0.01% | 6110 |
|
|
2016
Q1 | $1K | Sell |
1,497
-30,727
| -95% | -$20.5K | ﹤0.01% | 6627 |
|
|
2015
Q4 | $22K | Buy |
+32,224
| New | +$22K | ﹤0.01% | 5507 |
|
|
2015
Q1 | – | Sell |
-22
| Closed | – | – | 6956 |
|
|
2014
Q4 | $0 | Buy |
+22
| New | – | ﹤0.01% | 6829 |
|